Overall Survival Baseline, assessed every cycle until disease progression and then every 4 weeks until death, up to 30.65 months [clinicaltrials_resource:3012ad76abffe02aec67bd23e58b5872]
The time from date of randomization to date of death due to any cause. For participants who were alive, overall survival was censored at the last contact.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Overall Survival Baseline, assessed every cycle until disease progression and then every 4 weeks until death, up to 30.65 months [clinicaltrials_resource:3012ad76abffe02aec67bd23e58b5872]
The time from date of randomization to date of death due to any cause. For participants who were alive, overall survival was censored at the last contact.
Bio2RDF identifier
3012ad76abffe02aec67bd23e58b5872
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3012ad76abffe02aec67bd23e58b5872
measure [clinicaltrials_vocabulary:measure]
Overall Survival
time frame [clinicaltrials_vocabulary:time-frame]
Baseline, assessed every cycle ...... ntil death, up to 30.65 months
description
The time from date of randomiz ...... censored at the last contact.
identifier
clinicaltrials_resource:3012ad76abffe02aec67bd23e58b5872
title
Overall Survival Baseline, ass ...... ntil death, up to 30.65 months
@en
type
label
Overall Survival Baseline, ass ...... 2ad76abffe02aec67bd23e58b5872]
@en